Plan your participation at the ESMO Gynaecological Cancers Congress 2024, taking place onsite in Florence, Italy, and online, through a virtual platform.
We are excited to extend a warm invitation to ESMO Gynaecological Cancers Congress 2024, an event dedicated to advancing knowledge and innovations in the field of women's health and gynaecological oncology.
This event will showcase the latest advancements in gynaecological oncology, providing you with insights into ground breaking research, new treatment modalities, and emerging therapies.
You will also be able to connect with leading experts, researchers and clinicians from around the world, to forge collaborations that can drive innovation in the field.
ESMO Gynaecological Cancers 2024 is the ideal platform to showcase your latest products, technologies, and therapies. Engage with a targeted audience keen on advancements in gynaecological cancer care.
How can I participate at ESMO Gynaecological Cancers Congress 2024?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.
For sponsorship information and a prospectus please contact:
Jon Roberts
Head of Strategic Partnerships
jon.roberts@esmo.org
Anna MacDougall
Strategic Partnerships Manager
anna.macdougall@esmo.org
Francesca Iadicicco
Strategic Projects Manager
francesca.iadicicco@esmo.org
We look forward to hearing from you!
Official Italian agency for AIFA procedure
AIFA rules are mandatory for all Pharmaceutical Companies that will attend a congress in Italy.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Crisitina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu